444 related articles for article (PubMed ID: 29444783)
1. Mortality and quality of death certification in a cohort of patients with Parkinson's disease and matched controls in North Wales, UK at 18 years: a community-based cohort study.
Hobson P; Meara J
BMJ Open; 2018 Feb; 8(2):e018969. PubMed ID: 29444783
[TBL] [Abstract][Full Text] [Related]
2. Trends in Parkinson's disease related mortality in England and Wales, 1993-2006.
Mylne AQ; Griffiths C; Rooney C; Doyle P
Eur J Neurol; 2009 Sep; 16(9):1010-6. PubMed ID: 19538202
[TBL] [Abstract][Full Text] [Related]
3. How can the national burden of Parkinson's disease comorbidity and mortality be estimated for the Japanese population?
Doi Y; Yokoyama T; Nakamura Y; Nagai M; Fujimoto K; Nakano I
J Epidemiol; 2011; 21(3):211-6. PubMed ID: 21422700
[TBL] [Abstract][Full Text] [Related]
4. Causes of death in a community-based study of Parkinson's disease.
Beyer MK; Herlofson K; Arsland D; Larsen JP
Acta Neurol Scand; 2001 Jan; 103(1):7-11. PubMed ID: 11153892
[TBL] [Abstract][Full Text] [Related]
5. The estimated life expectancy in a community cohort of Parkinson's disease patients with and without dementia, compared with the UK population.
Hobson P; Meara J; Ishihara-Paul L
J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1093-8. PubMed ID: 20571039
[TBL] [Abstract][Full Text] [Related]
6. Mortality from Alzheimer's disease, Parkinson's disease, and dementias in France and Italy: a comparison using the multiple cause-of-death approach.
Désesquelles A; Demuru E; Salvatore MA; Pappagallo M; Frova L; Meslé F; Egidi V
J Aging Health; 2014 Mar; 26(2):283-315. PubMed ID: 24667337
[TBL] [Abstract][Full Text] [Related]
7. Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
Weintraub D; Chiang C; Kim HM; Wilkinson J; Marras C; Stanislawski B; Mamikonyan E; Kales HC
JAMA Neurol; 2016 May; 73(5):535-41. PubMed ID: 26999262
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of death certification of dementia in population-based samples of older people: analysis over time.
Gao L; Calloway R; Zhao E; Brayne C; Matthews FE;
Age Ageing; 2018 Jul; 47(4):589-594. PubMed ID: 29718074
[TBL] [Abstract][Full Text] [Related]
9. Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome).
Nath U; Thomson R; Wood R; Ben-Shlomo Y; Lees A; Rooney C; Burn D
J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):498-502. PubMed ID: 15774434
[TBL] [Abstract][Full Text] [Related]
10. Increase in Parkinson's disease-related mortality among males in Northern Italy.
Fedeli U; Schievano E
Parkinsonism Relat Disord; 2017 Jul; 40():47-50. PubMed ID: 28416129
[TBL] [Abstract][Full Text] [Related]
11. Under-reporting of Parkinson's disease on death certificates: a population-based study (NEDICES).
Benito-León J; Louis ED; Villarejo-Galende A; Romero JP; Bermejo-Pareja F
J Neurol Sci; 2014 Dec; 347(1-2):188-92. PubMed ID: 25292414
[TBL] [Abstract][Full Text] [Related]
12. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.
Williams-Gray CH; Mason SL; Evans JR; Foltynie T; Brayne C; Robbins TW; Barker RA
J Neurol Neurosurg Psychiatry; 2013 Nov; 84(11):1258-64. PubMed ID: 23781007
[TBL] [Abstract][Full Text] [Related]
13. [An analysis of causes of death in patients with Parkinson's disease].
Amosova NA; Smolentseva IG; Маslyuk ОА; Pavlov YV; Gavrilov EL
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6. Vyp. 2):70-72. PubMed ID: 28980616
[TBL] [Abstract][Full Text] [Related]
14. Survival time, mortality, and cause of death in elderly patients with Parkinson's disease: a 9-year follow-up.
Fall PA; Saleh A; Fredrickson M; Olsson JE; Granérus AK
Mov Disord; 2003 Nov; 18(11):1312-6. PubMed ID: 14639673
[TBL] [Abstract][Full Text] [Related]
15. Parkinson's disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990.
Gorell JM; Johnson CC; Rybicki BA
Neurology; 1994 Oct; 44(10):1865-8. PubMed ID: 7936238
[TBL] [Abstract][Full Text] [Related]
16. Causes of Death According to Death Certificates in Individuals with Dementia: A Cohort from the Swedish Dementia Registry.
Garcia-Ptacek S; Kåreholt I; Cermakova P; Rizzuto D; Religa D; Eriksdotter M
J Am Geriatr Soc; 2016 Nov; 64(11):e137-e142. PubMed ID: 27801938
[TBL] [Abstract][Full Text] [Related]
17. Mortality from Parkinson's disease in China: Findings from a five-year follow up study in Shanghai.
Wang G; Li XJ; Hu YS; Cheng Q; Wang CF; Xiao Q; Liu J; Ma JF; Zhou HY; Pan J; Tan YY; Wang Y; Chen SD
Can J Neurol Sci; 2015 Jul; 42(4):242-7. PubMed ID: 26153040
[TBL] [Abstract][Full Text] [Related]
18. Mortality in patients with Parkinson's disease.
Wermuth L; Stenager EN; Stenager E; Boldsen J
Acta Neurol Scand; 1995 Jul; 92(1):55-8. PubMed ID: 7572061
[TBL] [Abstract][Full Text] [Related]
19. Mortality and cause of death in South Korean patients with Parkinson's disease: a longitudinal follow-up study using a national sample cohort.
Choi HG; Lim JS; Lee YK; Sim S; Kim M
BMJ Open; 2019 Sep; 9(9):e029776. PubMed ID: 31530603
[TBL] [Abstract][Full Text] [Related]
20. Reporting of clinically diagnosed dementia on death certificates: retrospective cohort study.
Perera G; Stewart R; Higginson IJ; Sleeman KE
Age Ageing; 2016 Sep; 45(5):668-73. PubMed ID: 27146301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
